English
Related papers

Related papers: Immunological Density Shapes Recovery Trajectories…

200 papers

Moderate to severe post-acute sequelae of SARS-CoV-2 infection (PASC), also called long COVID, is estimated to impact as many as 10% of SARS-CoV-2 infected individuals, representing a chronic condition with a substantial global public…

Methodology · Statistics 2024-10-11 Harrison T. Reeder , Tanayott Thaweethai , Andrea S. Foulkes

It is shown that various symptoms could remain in the stage of post-acute sequelae of SARS-CoV-2 infection (PASC), otherwise known as Long COVID. A number of COVID patients suffer from heterogeneous symptoms, which severely impact recovery…

Quantitative Methods · Quantitative Biology 2022-11-17 Sihang Jiang , Johanna Loomba , Suchetha Sharma , Donald Brown

Based on recent studies, some COVID-19 symptoms can persist for months after infection, leading to what is termed long COVID. Factors such as vaccination timing, patient characteristics, and symptoms during the acute phase of infection may…

Machine Learning · Computer Science 2025-04-30 Milad Leyli-abadi , Jean-Patrick Brunet , Axel Tahmasebimoradi

Early prediction of Post-Acute Sequelae of SARS-CoV-2 severity is a critical challenge for women's health, particularly given the diagnostic overlap between PASC and common hormonal transitions such as menopause. Identifying and accounting…

Machine Learning · Computer Science 2026-03-19 Jing Wang , Jie Shen , Yiming Luo , Amar Sra , Qiaomin Xie , Jeremy C. Weiss

Post-acute sequelae of SARS-CoV-2 (PASC) is an increasingly recognized yet incompletely understood public health concern. Several studies have examined various ways to phenotype PASC to better characterize this heterogeneous condition.…

Quantitative Methods · Quantitative Biology 2023-08-09 Sarah Pungitore , Toluwanimi Olorunnisola , Jarrod Mosier , Vignesh Subbian

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a variable clinical presentation that ranges from asymptomatic, to severe disease with cytokine storm. The mortality rates also differ across the globe, ranging from 0.5-13%.…

Vaccines are among the most powerful tools used to combat the COVID-19 pandemic. They are highly effective against infection and substantially reduce the risk of severe disease, hospitalization, ICU admission, and death. However, their…

Quantitative Methods · Quantitative Biology 2022-04-07 Marc Wiedermann , Annika H. Rose , Benjamin F. Maier , Jakob J. Kolb , David Hinrichs , Dirk Brockmann

T-cells are central to SARS-CoV-2 clearance and immunological memory, yet their contribution to the persistence of post-acute sequelae of COVID-19 (PASC) remains poorly understood. The immunological features that distinguish individuals who…

SARS-CoV-2, the highly contagious pathogen responsible for the COVID-19 pandemic, has persistent effects that begin four weeks after initial infection and last for an undetermined duration. These chronic effects are more harmful than acute…

Post-acute sequelae of SARS-CoV-2 infection (PASC) or Long COVID is an emerging medical condition that has been observed in several patients with a positive diagnosis for COVID-19. Historical Electronic Health Records (EHR) like diagnosis…

Post-COVID Syndrome (PCS), encompassing the multifaceted sequelae of COVID-19, can be severity-graded using a score comprising 12 different long-term symptom complexes. Acute COVID-19 severity and individual resilience were previously…

The COVID-19 pandemic has left a significant mark on global healthcare, with many individuals experiencing lingering symptoms long after recovering from the acute phase of the disease, a condition often referred to as "long COVID." This…

Other Quantitative Biology · Quantitative Biology 2023-10-04 Maitham G. Yousif , Ghizal Fatima , Hector J. Castro , Fadhil G. Al-Amran , Salman Rawaf

Increasing number in global COVID-19 cases demands for mathematical model to analyze the interaction between the virus dynamics and the response of innate and adaptive immunity. Here, based on the assumption of a weak and delayed response…

Populations and Evolution · Quantitative Biology 2021-01-13 Zhengqing Zhou , Zhiheng Zhao , Shuyu Shi , Jianghua Wu , Dianjie Li , Jianwei Li , Jingpeng Zhang , Ke Gui , Yu Zhang , Heng Mei , Yu Hu , Qi Ouyang , Fangting Li

A significant percentage of COVID-19 survivors experience ongoing multisystemic symptoms that often affect daily living, a condition known as Long Covid or post-acute-sequelae of SARS-CoV-2 infection. However, identifying scientific…

Machine Learning · Computer Science 2022-10-31 Robert Leaman , Rezarta Islamaj , Alexis Allot , Qingyu Chen , W. John Wilbur , Zhiyong Lu

Long COVID is a general term of post-acute sequelae of COVID-19. Patients with long COVID can endure long-lasting symptoms including fatigue, headache, dyspnea and anosmia, etc. Identifying the cohorts with severe long-term complications in…

Machine Learning · Computer Science 2023-07-12 Degan Hao , Mohammadreza Negahdar

The long-term effects of Postacute Sequelae of SARS-CoV-2, known as PASC, pose a significant challenge to healthcare systems worldwide. Accurate identification of progression events, such as hospitalization and reinfection, is essential for…

Machine Learning · Computer Science 2025-07-01 Jing Wang , Amar Sra , Jeremy C. Weiss

Background. Long COVID symptoms (which include brain fog, depression, and fatigue) are mild at best and debilitating at worst. Some U.S. health surveys have found that women, lower income individuals, and those with less education are…

General Economics · Economics 2026-03-05 Jennifer Cohen , Yana Rodgers

Long COVID is a multisystem condition characterized by persistent symptoms such as fatigue, cognitive impairment, and systemic inflammation, following COVID-19 infection, yet its mechanisms remain poorly understood. In this study, we…

Molecular Networks · Quantitative Biology 2025-01-30 Jaesub Park , Woochang Hwang , Seokjun Lee , Hyun Chang Lee , Méabh MacMahon , Matthias Zilbauer , Namshik Han

COVID-19 vaccines are highly efficacious at preventing symptomatic infection, severe disease, and death. Most of the evidence that COVID-19 vaccines also reduce transmission of SARS-CoV-2 is based on retrospective, observational studies.…

Applications · Statistics 2022-06-16 Marlena S. Bannick , Fei Gao , Elizabeth R. Brown , Holly E. Janes

Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages…

‹ Prev 1 2 3 10 Next ›